CRTR4

GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults

Association between chemotherapy use and prognosis in young patientswith stage I-II ER+/HER2-negative breast cancer according to Prosigna®:An international real-world analysis with propensity-score matching